Cyclacel
Investors & Media
<< Back

12/01/16

EORTC-NCI-AACR 2016. Abstract 355: Therapeutic potential of novel PLK1 inhibitor, CYC140, in esophageal cancer and acute leukemia

  
EORTC-NCI-AACR 2016. Abstract 355: Therapeutic potential of novel PLK1 inhibitor, CYC140, in esophageal cancer and acute leukemia
Investors & Media